SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,572 Cr | ₹1,531 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,572 Cr |
| Mar2024 | ₹1,531 Cr |
| Mar2023 | ₹1,484 Cr |
| Mar2022 | ₹1,487 Cr |
| Mar2021 | ₹1,443 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,572 Cr | 2.68 | |
| Mar2024 | ₹1,531 Cr | 3.19 | |
| Mar2023 | ₹1,484 Cr | -0.19 | |
| Mar2022 | ₹1,487 Cr | 3.02 | |
| Mar2021 | ₹1,443 Cr | - | |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹8,534.8 Cr | 4.4% | -2.3% | 45% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 4.4% |
-2.3% |
45% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses